EGFR and central nervous system cancer: They reported EGFR Affibody–IR700Dye conjugate specific uptake in vitro enabled imaging of EGFR expression in an orthotopic brain tumor model, and an NIR-PIT study in vivo demonstrated therapeutic efficacy of the conjugate in a subcutaneous glioma xenograft model [19].